Jing Luo, MD, MPH

Jump to Selected Publications

Faculty, Program on Regulation, Therapeutics and Law

Brigham & Women’s Hospital
Department of Medicine
Division of Pharmacoepidemiology & Pharmacoeconomics
1620 Tremont Street, Suite 3030,
Boston, MA 02120

jluo1@partners.org
Phone: 617-732-4849 | Fax: 617-232-8602

Jing Luo, M.D., M.P.H., is an Instructor of Medicine at Harvard Medical School and a faculty member in the Division of Pharmacoepidemiology and Pharmacoeconomics in the Department of Medicine at Brigham and Women’s Hospital. He graduated from Duke University and the University of Illinois at Chicago College of Medicine, where he was an NIH-Fogarty International Clinical Research Scholar. He trained in Primary Care Internal Medicine at Yale-New Haven Hospital. He obtained a Masters of Public Health at the T.H. Chan School of Public Health as part of the Harvard-wide general medicine fellowship. He is Board Certified in Internal Medicine, and serves as an associate physician at the Phyllis Jen Center for Primary Care at BWH and at Harvard University Health Services. His research focuses on prescription drug pricing, access to medicines and generic competition.

Dr. Luo’s work has appeared in JAMA, JAMA Internal Medicine, Lancet Diabetes & Endocrinology and the Harvard Health Policy Review. He is a member of the Program On Regulation, Therapeutics, And Law (PORTAL), under the direction of faculty member Dr. Aaron Kesselheim. Dr. Luo also serves as a clinical consultant to Alosa Health, a non-profit organization that promotes evidence-based prescribing and academic detailing.

Selected Publications | Current PubMed Search Results

  • Luo J, Seeger JD, Donneyong M, Gagne JJ, Avorn J, Kesselheim AS. Effect of generic competition on Atorvastatin prescribing and patients’ out-of-pocket spending. JAMA Intern Med. 2016 Sep 1;176(9):1317-23
  • Luo J, Kesselheim AS. Protecting pharmaceutical patents and test data: how the Trans-Pacific Partnership Agreement could affect access to medicines in the US and abroad. AMA J Ethics 2016;18(7):727-35
  • Luo J, Avorn J, Kesselheim AS. Inaccurate reporting of insulin reimbursement-reply. JAMA 2016 Mar;176(6):408-9
  • Luo J, Kesselheim AS. Insulin patents and market exclusivities: unresolved issues-Author’s reply. Lancet Diabetes2016 Feb;4(2):98-9
  • Luo J, Kesselheim AS. Cost-effectiveness of statin therapy for ASCVD. JAMA2015 Nov 24;314(20):2191
  • Luo J, Sarpatwari A, Kesselheim AS. Regulatory solutions to the problem of high generic drug costs. Open Forum Infect Dis. 2015 Dec;2(4):ofv179
  • Luo J, Kesselheim AS. The Trans-Pacific Partnership Agreement and implications for access to essential medicines. JAMA 2015 Oct 20;314(15):1563-4
  • Luo J, Kesselheim AS. Evolution of insulin patents and market exclusivities in the USA. Lancet Diabetes Endocrinol. 2015 Nov;3(11):835-7
  • Luo J, Avorn J, Kesselheim AS. Trends in Medicaid reimbursements for insulin from 1991 through 2014.  JAMA Intern Med. 2015 Oct;175(10):1681-6
  • Luo J, Oliveira MA, Ramos MB, Maia A, Osorio-de-Castro CG. Antiretroviral drug expenditure, pricing and judicial demand: an analysis of federal procurement data in Brazil from 2004-2011. BMC Public Health. 2014;14:367
  • Luo J, Kesselheim AS. Underrepresentation of older adults in cancer trials. JAMA. 2014 Mar 5;311(9):965-6
  • Luo J, Weine S, Bahromov M, Golobof A. Does powerlessness explain elevated HIV risk amongst Tajik labor migrants? An ethnographic study. Journal of HIV/AIDS & Social Services. 2012;11(2):105-124
  • Tucker JD, Chang H, Brandt A, Gao X, Lin M, Luo J, Song P, Sun K, Zhang X. An empirical analysis of overlap publication in Chinese language and English research manuscripts.  PLoS One. 2011;6(7):e22149
  • Golobof A, Weine S, Bahromov M, Luo J. The role of labor migrants’ wives in HIV/AIDS risk and prevention in Tajikistan. AIDS Care. 2011 Jan;23(1):91-7
  • Lu W, Zeng G, Luo J, Duo S, Xing G, Guo-Wei D, Jian-Ping Z, Wen-Sheng H, Ning W. HIV transmission risk among serodiscordant couples: a retrospective study of former plasma donors in Henan, China. J Acquir Immune Defic Syndr. 2010 Oct 1;55(2):232-238